Credissential Inc. (IPTNF)

Chimerix Income Statement

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	0	0.02	0.06	0.1	0.04	0.06
Revenue Growth (YoY)	-92.23%	-63.50%	-41.80%	160.79%	-33.33%	-
Gross Profit	0	0.02	0.06	0.1	0.04	0.06
Selling, General & Admin	3.02	1.85	0.04	0.04	0.05	0.15
Research & Development	0.48	0.38	-	-	-	-
Operating Expenses	11.3	2.67	0.04	0.04	0.11	0.2
Operating Income	-11.3	-2.65	0.02	0.07	-0.07	-0.14
Interest Expense	-0.1	-0.13	-0	-0	-0	-0
Currency Exchange Gain (Loss)	-0.04	-0.01	-	-	-	-
Other Non Operating Income (Expenses)	-4.06	-0.01	-0.02	-0.02	-0.02	-0.05
EBT Excluding Unusual Items	-15.5	-2.8	0	0.05	-0.09	-0.19
Asset Writedown	-	-	-	-	-0.07	-
Pretax Income	-15.5	-2.8	0	0.05	-0.15	-0.19
Net Income	-15.5	-2.8	0	0.05	-0.15	-0.19
Net Income to Common	-15.5	-2.8	0	0.05	-0.15	-0.19
Net Income Growth	-	-	-97.63%	-	-	-
Shares Outstanding (Basic)	44	27	26	26	26	23
Shares Outstanding (Diluted)	44	27	26	26	26	23
Shares Change (YoY)	105.95%	4.13%	-	-	11.67%	-
EPS (Basic)	-0.36	-0.10	0.00	0.00	-0.01	-0.01
EPS (Diluted)	-0.36	-0.10	0.00	0.00	-0.01	-0.01
EPS Growth	-	-	-97.67%	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-451989.80%	-11944.93%	35.94%	63.70%	-175.22%	-226.18%
Profit Margin	-620175.92%	-12654.87%	1.83%	44.81%	-386.24%	-317.98%
EBITDA	-	-	-	0.11	-0.03	-0.09
EBITDA Margin	-	-	-	103.64%	-71.06%	-156.74%
D&A For EBITDA	-	-	-	0.04	0.04	0.04
EBIT	-11.3	-2.65	0.02	0.07	-0.07	-0.14
EBIT Margin	-	-	35.94%	63.70%	-175.22%	-226.18%
Revenue as Reported	0.02	0.02	0.06	-	0.04	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.